|
Volumn 20, Issue 22, 2010, Pages 6518-6523
|
Aminoalkylcarbamoylphosphonates reduce TNFα release from activated immune cells
|
Author keywords
Carbamoylphosphonate; Inflammation; Matrix metalloproteinase inhibitor; Phosphonate; TACE; TNF
|
Indexed keywords
2 AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID;
ANTIINFLAMMATORY AGENT;
BUDESONIDE;
CARBAMIC ACID DERIVATIVE;
LIPOPOLYSACCHARIDE;
MATRIX METALLOPROTEINASE;
N [ 2 (1 PIPERIDINO)ETHYL] CARBAMOYLPHOSPHONIC ACID;
N [ 2 (1 PYRROLIDINO)ETHYL]CARBAMOYLPHOSPHONIC ACID;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BIOLOGICAL ACTIVITY;
CELL PROLIFERATION;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG INHIBITION;
DRUG STRUCTURE;
IMMUNOCOMPETENT CELL;
IN VITRO STUDY;
MOUSE;
NONHUMAN;
PERITONEUM MACROPHAGE;
SPLEEN CELL;
ANIMALS;
MACROPHAGES, PERITONEAL;
MICE;
PHOSPHONIC ACIDS;
SPLEEN;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 77958056213
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.09.048 Document Type: Article |
Times cited : (7)
|
References (30)
|